Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fubotv Inc (FUBO) vs Philip Morris International Inc. (PM) Price & Performance

Fubotv IncTrade
Philip Morris International Inc.Trade

Price performance (Past 24H)

Key statistics

Fubotv Inc vs Philip Morris International Inc. — how do they compare? Fubotv Inc trades at $9.32 (market cap $1.02B), while Philip Morris International Inc. trades at $200.27 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 306.4× Fubotv Inc's market cap, and Philip Morris International Inc. pays a 3.19% dividend while Fubotv Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fubotv Inc for 35 Days and Philip Morris International Inc. for 85 Days on average.

FUBOPM
Market Cap
$1.02B$312.50B
Volume
978,6315,517,172
Sector
MediaConsumer Staples
52-Week High
$48.96$200.50
52-Week Low
$8.09$144.33
Typical Hold Time
35 Days85 Days
Enterprise Value
$1.19B$355.62B
Dividend Yield
—3.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fubotv Inc

FUBO trades at $9.25, up 4.76% today, showing technical bearish signals with mixed earnings performance. The company reported Q2 2026 EPS of -$0.25, beating expectations, but missed in Q4 2025. Revenue growth has been strong, reaching $1.62B in 2024 with improving profit margins. Recent developments include new sports streaming agreements and Disney partnership integration driving subscriber growth.

FUBO presents a speculative opportunity with deep valuation discounts (P/E 2.43, P/S 0.19) but faces execution risks amid persistent cash burn. Analyst consensus is mixed with 47% buy ratings and $63.38 price target, representing significant upside potential if turnaround succeeds. Key risks include competitive pressure and path to sustained profitability.

Philip Morris International Inc.

Philip Morris International (PM) trades at $192.69, up 1.2% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 EPS beat expectations at $2.20 vs. $2.05, and revenue growth accelerated to $40.65B in 2025. The company's smoke-free products now drive 42% of revenue, with ZYN and IQOS expansions fueling optimism. Cash flow remains robust, with 2026 operating cash flow projected at $14.3B, supporting dividend growth.

Outlook is positive given earnings momentum and smoke-free transition, but high debt ($42.17B long-term) and regulatory risks persist. The consensus price target of $212.17 implies ~10% upside, though valuation multiples are elevated versus peers. Key risks include FX volatility and slower adoption of next-gen products.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FUBO
26% Buy74% Sell
Avg holding period · 35 Days
PM
10% Buy90% Sell
Avg holding period · 85 Days

Top news

Latest headlines on both assets

About Fubotv Inc

FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.

Read more on FUBO →

About Philip Morris International Inc.

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Read more on PM →